Fexofenadine HCl and Pseudoephedrine HCI NDC 55111-557

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-557Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0557Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-557-07	55111055707	1 BLISTER PACK in 1 CARTON (55111-557-07) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Aug 24, 2011
55111-557-29	55111055729	3 BLISTER PACK in 1 CARTON (55111-557-29) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Aug 24, 2011
55111-557-35	55111055735	2 BLISTER PACK in 1 CARTON (55111-557-35) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Aug 24, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fexofenadine HCl and Pseudoephedrine HCI
Generic name (nonproprietary): fexofenadine hcl and pseudoephedrine hci
Active ingredients: Fexofenadine hydrochloride — 180 mg/1Pseudoephedrine hydrochloride — 240 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Dr.Reddy's Laboratories Limited
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079043
Marketing start: Aug 24, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55111-557_29216032-68a5-566a-5eaf-ffc9cb597e9aSPL ID 29216032-68a5-566a-5eaf-ffc9cb597e9aSPL set ID 25cca459-fdd6-3847-2207-dd4f019781b5RxCUI 997415UNII 2S068B75ZU, 6V9V2RYJ8N
Pharmacologic class: Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111055707 followed by a unit qualifier and the quantity

Package 55111-0557-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2018.

Indications (excerpt from the label)

Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)